RRR-α-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA- MB-435 breast cancer cells

Molecular Carcinogenesis

Volumn 22, Issue 4, 1998, Pages 247-257

  Yu, Weiping ^a   Simmons Menchaca, Maria ^a   You, Huihong ^a   Brown, Powel ^b   Birrer, Michael J ^c   Sanders, Bob G ^a   Kline, Kimberly ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AP 1 transactivation; Apoptosis; C Jun; Human breast cancer cells; JNK; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE;

APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ADENOVIRIDAE;

EID: 0031875326     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199808)22:4<247::AID-MC6>3.0.CO;2-G     Document Type: Article

References (61)

1. Prasad KN, Edwards-Prasad J. Vitamin E and cancer prevention: Recent advances and future potentials. J Am Coll Nutr 11:487-500, 1992.
2. Kline K, Yu W, Zhao B, et al. Vitamin E succinate: Mechanisms of action as tumor cell growth inhibitor. In: Prasad KN, Santamaria L, Williams RM (eds), Nutrients in Cancer Prevention and Treatment. Humana, Totowa, NJ, 1995, pp. 39-56.
3. Kline K, Yu W, Sanders BG. Vitamin E: Mechanisms of action as tumor cell growth inhibitors. In. Prasad KN, Cole, WC (eds), Nutrition and Cancer. IOS Press, Amsterdam, 1998, pp. 37-53.
4. Turley JM, Sanders BG, Kline KK. RRR-α-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr Cancer 18:201-213, 1992.
5. Charpentier A, Groves S, Simmons-Menchaca M, et al. RRR-α-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-β (TGF-β) by human breast cancer cells. Nutr Cancer 19:225-239, 1993.
6. Simmons-Menchaca M, Qian M, Yu W, Sanders BG, Kline K. RRR-α-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-β by avian retrovirus-transformed lymphoid cells. Nutr Cancer 24:171-185, 1995.
7. Turley JM, Funakoshi S, Ruscetti FW, et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor β. Cell Growth Differ 6:655-663, 1995.
8. Yu W, Sanders BG, Kline K. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate. Nutr Cancer 25:138-149, 1996.
9. Charpentier A, Simmons-Menchaca M, Yu W, et al. RRR-α-tocopheryl succinate enhances TGF-β1, -β2, and -β3, and TGF-βR-II expression by human MDA-MB-435 breast cancer cells. Nutr Cancer 26:237-250, 1996.
10. Qian M, Sanders BG, Kline K. RRR-α-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells. Nutr Cancer 25:9-26, 1996.
11. Yu W, Heim K, Qian M, et al. Evidence for role of transforming growth factor-β in RRR-α-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer 27:267-278, 1997.
12. Zhao-B, Yu W, Qian M, et al. Induction of apoptosis by RRR-α-tocopheryl succinate in human breast cancer cells involves AP-1. Mol Carcinog 19:180-190, 1997.
13. Qian M, Kralova J, Yu W, et al. c-jun involvement in vitamin E succinate induced apoptosis of reticulendotheliosis virus transformed avian lymphoid cells. Oncogene 15:223-230, 1997.
14. Turley JM, Fu T, Ruscetti FW, et al. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res 57:881-890, 1997.
15. Yu W, Sanders BG, Kline K. RRR-α-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr Cancer 27:92-101, 1997.
16. Kelloff GJ, Crowell JA, Boone CW, et at. Development plans for cancer chemopreventive agents. J Cell Biochem Suppl 20:282-294, 1994.
17. Slack R, Proulx P. Studies on the effects of vitamin E on neuroblastoma NIE 115. Nutr Cancer 12:75-82, 1989.
18. Traber MG, Thellman CA, Rindler MJ, Kayden HJ. Uptake of intact TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) a water-miscible form of vitamin E by human cells in vitro. Am J Clin Nutr 48:605-611, 1988.
19. Cohen PS, Letterio JJ, Gaetano C, et al. Induction of transforming growth factor β1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res 55:2380-2386, 1995.
20. Letterio JJ, Anzano MA, Roberts AB, Sporn MB. Novel vitamin D analog enhances differentiating effects of transforming growth factor beta-1 (TGF-β) in myeloid leukemia cell lines. Abstract. Proceedings of the American Association for Cancer Research 34:46, 1993.
21. 3 in MG-63 osteoblastic cells. Biochem Biophys Res Commun 204:918-923, 1994.
22. 3 enhances the expression of transforming growth factor β1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res 55:1540-1546, 1995.
23. Colletta AA, Wakefield LM, Howell FV, et al. Anti-ooestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer 62:405-409, 1990.
24. Butta A, MacLennan K, Flanders KC, et al. Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res 52:4261-4264, 1992.
25. Wakefield L, Kim S-J, Glick A, et al. Regulation of transforming growth factor-β subtypes by members of the steroid hormone superfamily. J Cell Sci Suppl 13:139-148, 1990.
26. Mills JJ, Chari RS, Boyer IJ, et al. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55:979-983, 1995.
27. Haag JD, Lindstrom MJ, Gould MN. Limonene-induced regression of mammary carcinomas. Cancer Res 52:4021-4026, 1992.
28. Haag JD, Gould MN. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 34:477-483, 1994.
29. Moore DD. Diversity and unity in the nuclear hormone receptors: A terpenoid receptor superfamily. The New Biologist 2:100-105, 1990.
30. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast cancer carcinoma cell lines in nude mice. Cancer Res 50:717-721, 1990.
31. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1982.
32. Goldstone SD, Lavin MF. Prolonged expression of c-jun and associated activity of the transcription factor AP-1 during apoptosis in a human leukaemic cell line. Oncogene 9:2305-2311, 1994.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970.
34. Johnson NL, Gardner AM, Diener GK, et al. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 271:3229-3237, 1996.
35. Westwick JK, Brenner DA. Methods for analyzing c-jun kinase. Methods Enzymol 255:342-359, 1995.
36. Gupta S, Barrett T, Whitmarsh AJ, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15:2760-2770, 1996.
37. Akahane K, Cohen RB, Bickel M, Pluznik DH. IL-1α induces granulocyte-macrophage colony-stimulating factor gene expression in murine B lymphocyte cell lines via mRNA stabilization. J Immunol 146:4190-4196, 1991.
38. Offord EA, Chappuis PO, Beard P. Different stability of AP1 proteins in human keratinocyte and fibroblast cells: Possible role in the cell-type specific expression of human papillomavirus type 18 genes. Carcinogenesis 14:2447-2455, 1993.
39. Sutterluety H, Bartl S, Karlseder J, Wintersberger E, Seiser CJ. Carboxy-terminal residues of mouse thymidine kinase are essential for rapid degradation in quiescent cells. J Mol Biol 259:383-392, 1996.
40. Turley JM, Ruscetti FW, Kim S-J, et al. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: Increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res 57:2668-2675, 1997.
41. McMahon SB, Monroe JG. Role of primary response genes in generating cellular responses to growth factors. FASEB J 6:2707-2715, 1992.
42. Angel P, Karin M. The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157, 1991.
43. Estus S, Zaks WJ, Freeman RS, et al. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127:1717-1727, 1994.
44. Ham J, Babij C, Whitfield J, et al. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939, 1995.
45. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995.
46. Karin M, Liu Z-G, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 9:240-249, 1997.
47. Chen Y-R, Wang X, Templeton D, Davis RJ, Tan T-H. The role of c-jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J Biol Chem 271:31929-31936, 1996.
48. Angel P, Herrlich P. General structure of apoptosis subunits and characteristics of the jun proteins. In: Angel PE, Herrlich PA (eds). The Fos and Jun Families of Transcription Factors. CRC Press, Boca Raton, FL, 1994, pp. 3-14.
49. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev 7:2135-2148, 1993.
50. Derijard B, Hibi M, Wu I-H, et al. A protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell 76:1025-1037, 1994.
51. Dai T, Rubie E, Franklin C, et al. Stress-activated kinases bind directly to the δ domain of c-jun in resting cells: Implications for repression of c-jun function. Oncogene 10:849-855, 1995.
52. Karin M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Biol 6:415-424, 1994.
53. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486, 1995.
54. Brown PH, Alani R, Preis LH, Szabo E, Birrer MJ. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 81:877-886, 1993.
55. Brown PH, Chen TK, Birrer MJ. Mechanism of action of a dominant-negative mutant of c-jun. Oncogene 9:791-800, 1994.
56. van Dam H, Duynham M, Rottier R, et al. Heterodimer formation of c-jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J 12:479-487, 1993.
57. van Dam H, Wilhelm D, Herr I, et al. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14:1798-1811, 1995.
58. Livingstone C, Patel G, Jones N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J 14:1785-1797, 1995.
59. Dong Z, Birrer M, Watts R, Matrisian L, Colburn N. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 91:609-613, 1994.
60. Azzi A, Boscoboinik D, Marilley D, et al. Vitamin E: A sensor and an information transducer of the cell oxidation state. Am J Clin Nutr 62:1337S-1347S, 1995.
61. Djavaheri-Mergny M, Mergny J-L, Bertrand F, et al. Ultraviolet-A induces activation of AP-1 in cultured human keratinocytes. FEBS Lett 384:92-96, 1996.